These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 31207390)

  • 21. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.
    Kurbatskaya K; Phillips EC; Croft CL; Dentoni G; Hughes MM; Wade MA; Al-Sarraj S; Troakes C; O'Neill MJ; Perez-Nievas BG; Hanger DP; Noble W
    Acta Neuropathol Commun; 2016 Mar; 4():34. PubMed ID: 27036949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional distribution of tau, beta-amyloid and beta-amyloid precursor protein in the Alzheimer's brain: a quantitative immunolabelling study.
    Shukla C; Bridges LR
    Neuroreport; 1999 Dec; 10(18):3785-9. PubMed ID: 10716210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
    Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
    Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
    Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues.
    Muraoka S; DeLeo AM; Sethi MK; Yukawa-Takamatsu K; Yang Z; Ko J; Hogan JD; Ruan Z; You Y; Wang Y; Medalla M; Ikezu S; Chen M; Xia W; Gorantla S; Gendelman HE; Issadore D; Zaia J; Ikezu T
    Alzheimers Dement; 2020 Jun; 16(6):896-907. PubMed ID: 32301581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer's disease continuum.
    Denning AE; Ittyerah R; Levorse LM; Sadeghpour N; Athalye C; Chung E; Ravikumar S; Dong M; Duong MT; Li Y; Ilesanmi A; Sreepada LP; Sabatini P; Lowe M; Bahena A; Zablah J; Spencer BE; Watanabe R; Kim B; Sørensen MH; Khandelwal P; Brown C; Hrybouski S; Xie SX; de Flores R; Robinson JL; Schuck T; Ohm DT; Arezoumandan S; Porta S; Detre JA; Insausti R; Wisse LEM; Das SR; Irwin DJ; Lee EB; Wolk DA; Yushkevich PA
    Acta Neuropathol; 2024 Sep; 148(1):37. PubMed ID: 39227502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer's Disease.
    Zhang J; Liu Q; Zhang H; Dai M; Song Q; Yang D; Wu G; Chen M
    J Alzheimers Dis; 2023; 95(3):1201-1219. PubMed ID: 37661878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased between-network connectivity: A risk factor for tau elevation and disease progression.
    Hojjati SH; Butler TA; Luchsinger JA; Benitez R; de Leon M; Nayak S; Razlighi QR; Chiang GC
    Neurosci Lett; 2024 Sep; 840():137943. PubMed ID: 39153526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric-Aβ mediates pathology maturation.
    Darricau M; Dou C; Kinet R; Zhu T; Zhou L; Li X; Bedel A; Claverol S; Tokarski C; Katsinelos T; McEwan WA; Zhang L; Gao R; Bourdenx M; Dehay B; Qin C; Bezard E; Planche V
    Alzheimers Dement; 2024 Mar; 20(3):1894-1912. PubMed ID: 38148705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    Chen M; Xia W
    J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease.
    Murray CE; Gami-Patel P; Gkanatsiou E; Brinkmalm G; Portelius E; Wirths O; Heywood W; Blennow K; Ghiso J; Holton JL; Mills K; Zetterberg H; Revesz T; Lashley T
    Acta Neuropathol Commun; 2018 Jul; 6(1):62. PubMed ID: 30029687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
    Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset.
    Chen L; Baum L; Ng HK; Chan LY; Pang CP
    Hum Pathol; 1999 Oct; 30(10):1172-7. PubMed ID: 10534164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.
    Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA
    J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.
    Abreha MH; Dammer EB; Ping L; Zhang T; Duong DM; Gearing M; Lah JJ; Levey AI; Seyfried NT
    Proteomics; 2018 Oct; 18(20):e1800108. PubMed ID: 30230243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.